Skip to main content
. Author manuscript; available in PMC: 2015 Oct 1.
Published in final edited form as: J Investig Med. 2014 Oct;62(7):920–926. doi: 10.1097/JIM.0000000000000106

Table 2.

Patient characteristics

All patients
(n=2,017)
Under 40
(n=219)
Over 40
(n=1,798)
p
Age (mean ± SD) 51.5 ± 10.7 34.0 ± 4.7 53.7 ± 9.2 <0.001
Female 679 68 (10%) 611 (90%) 0.405
Male 1338 151 (13%) 1187 (87%) 0.257
Ethnicity
  White 802 87 (11%) 715 (89%) 1
  African American 550 31 (6%) 519 (94%) <0.001
  Hispanic 550 89 (16%) 461 (84%) <0.001
  Asian/Pacific Islander/East Indian 36 3 (8%) 33 (92%) 0.791
  American Indian/Alaska Native 19 2 (11%) 17 (89%) 1
  Other 60 7 (12%) 53 (88%) 0.832
Cause of Cirrhosis
  Alcoholic 921 98 (11%) 823 (89%) 0.706
  Autoimmune 25 12 (48%) 13 (52%) <0.001
  Cryptogenic/NAFLD/NASH 173 8 (5%) 165 (95%) 0.003
  HBV 73 9 (12%) 64 (88%) 0.108
  HCV 719 73 (10%) 646 (90%) <0.001
  HBV & HCV 38 5 (13%) 33 (87%) 0.598
  PBC/PSC 30 5 (17%) 25 (83%) 0.366
  Other* 38 9 (24%) 29 (76%) 0.037
Medical History
  Diabetes Mellitus 437 18 (4%) 419 (96%) <0.001
  Diabetes Mellitus w Organ Damage 50 1 (2%) 49 (98%) 0.037
  Hepatocellular Carcinoma 41 0 (0%) 41 (100%) 0.019
  Chronic Kidney Disease 36 8 (28%) 28 (72%) 0.0502
  AIDS 68 20 (29%) 48 (71%) <0.001
  Esophageal Varices 340 53 (16%) 287 (84%) 0.003

All values reported as N or N (%).

*

Other includes cardiac, congenital, Sarcoidosis, Wilson’s disease, chronic granulomatous infection, and hemochromatosis.

HBV, hepatitis B virus; HCV, hepatitis C virus; NAFLD/NASH, nonalcoholic fatty liver disease/nonalcoholic steatohepatitis; PBC, primary biliary cirrhosis; PSC, primary sclerosing cholangitis